Consideration of Pannexin 1 channels in COVID-19 pathology and treatment

Am J Physiol Lung Cell Mol Physiol. 2020 Jul 1;319(1):L121-L125. doi: 10.1152/ajplung.00146.2020. Epub 2020 Jun 10.
No abstract available

Keywords: COVID-19; Pannexin 1; SARS-CoV-2; endothelium.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Betacoronavirus / drug effects
  • Betacoronavirus / pathogenicity*
  • COVID-19
  • Connexins / drug effects*
  • Coronavirus Infections / drug therapy
  • Coronavirus Infections / pathology*
  • Coronavirus Infections / virology*
  • Humans
  • Nerve Tissue Proteins / drug effects*
  • Pandemics
  • Pneumonia, Viral / diagnosis
  • Pneumonia, Viral / drug therapy
  • Pneumonia, Viral / pathology*
  • Pneumonia, Viral / virology*
  • SARS-CoV-2

Substances

  • Connexins
  • Nerve Tissue Proteins
  • PANX1 protein, human